Last reviewed · How we verify

NCT06121115

Norepinephrine Administration Through a Midline Catheter in an Intermediate Care Unit

Completed Last updated 12 March 2024
What this trial tests

trial testing Norepinephrine in Septic Shock in 473 participants. Completed in 1 March 2024.

Timeline
3 October 2023
Primary endpoint
1 March 2024
1 March 2024

Quick facts

Lead sponsorRegion Skane
StatusCompleted
Study typeOBSERVATIONAL
Enrollment473
Start date3 October 2023
Primary completion1 March 2024
Estimated completion1 March 2024
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Region Skane — full company profile →

Who can join

18 and older, any sex, with Septic Shock or Norepinephrine Adverse Reaction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a single-center study retrospectively evaluating a local clinical routine to administer norepinephrine in midline catheters, with regard to complications and patient outcomes

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Treating shock with norepinephrine administered in midline catheters in an intermediary care unit: a retrospective cohort study.
    Karlsson H, Afrasiabi A, Ohlsson M, Månsson V, et al · · 2024 · cited 2× · PMID 39806688 · DOI 10.1136/bmjopen-2024-091311

Verify or expand the search:

Other trials of Norepinephrine

Trials testing the same drug.

Other recruiting trials for Septic Shock

Currently open trials in the same condition.

Other Region Skane trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06121115.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing